Lv511
1100 积分 2024-08-10 加入
An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
9天前
已完结
Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB
9天前
已完结
Interleukin-17 in Liver Disease Pathogenesis
1个月前
已完结
The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms
1个月前
已完结
High accuracy model for HBsAg loss based on longitudinal trajectories of serum qHBsAg throughout long-term antiviral therapy
1个月前
已完结
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
2个月前
已完结
Hepatic danger signaling triggers TREM2+ macrophage induction and drives steatohepatitis via MS4A7-dependent inflammasome activation
2个月前
已完结
FGF21 Agonists: An Emerging Therapeutic for Metabolic Dysfunction-Associated Steatohepatitis and Beyond
2个月前
已完结
A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis
2个月前
已完结
Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease – the role of transient elastography and plasma cytokeratin‐18 fragments
2个月前
已完结
皖公网安备34019202002308
